Proliferative Hairy Cell Leukaemia (HCL-v) Resistant to Alpha-Interferon: Clinical, Diagnostic and In-Vitro Cellular Characteristics

References

• Quesada J. R., Reuben J., Manning J. T., Hersh E. M., Gutterman J. U. Alpha interferon for induction of remission in hairy cell leukemia. N. Engl. J. Med. 1984; 310: 15–18
   PubMed Web of Science ®Google Scholar
• Ratain M. J., Vardiman J. W., Goiomb H. M. The role of interferon in the treatment of hairy cell leukemia. Semin. Oncol 1986; 13: 21–28
   PubMed Web of Science ®Google Scholar
• Worman C. P., Catovsky D., Cawley J. C., Bevan P. C., Bottomley J. M., Nethersell A. B. W. The UK experience with human lymphoblastoid interferon in HCL: A report of the first 50 cases. Leukemia 1987; 1: 320–322
   PubMed Web of Science ®Google Scholar
• Cawley J. C., Burns G. F., Hayhoe F. G. J. A chronic lymphoproliferative disorder with distinctive features: A distinct variant of hairy-cell leukaemia. Leuk. Res. 1980; 4: 547–559
   PubMed Web of Science ®Google Scholar
• Catovsky D., O'Brien M., Melo J. V., Wardle J., Brozovic M. Hairy cell leukemia (HCL) variant: An intermediate disease between HCL and B prolymphocytic leukemia. Semin. Oncol. 1984; 11: 362–369
   PubMed Web of Science ®Google Scholar
• Giardina S. L., Young H. A., Faltynek C. R., Jaffe E. S., Clark J. W., Steis R. G., Urba W. J., Mathieson B. J., Gralnick H., Lawrence J., Overton W. R., Longo D. L. Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia resistant to interferon-alpha. Blood 1988; 72: 1708–1716
   PubMed Web of Science ®Google Scholar
• Scott C. S. Cytochemical and immunocytochemical techniques (Chapter 14). 'Leukaemia Cytochemistry and Diagnosis: Principles and Practice', C. S. Scott. Ellis Horwood, Chichester 1989; 362–379
   Google Scholar
• Swanson R. A., Tracy R. P., Mann J. A., Wilson D. M., Young D. S. β2-microglobulin determined by radioimmunoassay with monoclonal antibody. Clin. Chem. 1982; 28: 2033–2039
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Brenner M. K., Coustan-Smith E., Wickremasinghe R. G., Hoffbrand A. V. Synergistic action of calcium ionophore A23187 and phorbol ester TPA on B-chronic lymphocytic leukemia cells. Blood 1987; 70: 1536–1542
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Gaedicke G., Minowada J. Occurrence of particular isoenzymes in fresh and cultured leukaemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme. Cancer 1986; 57: 1776–1872
   PubMed Web of Science ®Google Scholar
• Polliack A., Gurfel D., Or R., Leizerowitz R., Gazitt Y. Hairy cell leukaemia: Effects of phorbol ester on cell morphology and adherence and comparison with other B-cell neoplasias. Scand. J. Haematol. 1986; 36: 358–366
   PubMedGoogle Scholar
• Li C. Y., Yam L. T., Lam K. W. Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions. J. Histochem. Cytochem 1970; 18: 473–481
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Brenner M. K., Gignac S. M., Hoffbrand A. V. Expression of tartrate-resistant acid phosphatase in B-CLL treated with phorbol ester or phorbol ester plus calcium ionophore. Eur. J. Haematol. 1988; 41: 250–257
   PubMed Web of Science ®Google Scholar
• Burke J. S., Rappaport H. The diagnosis and differential diagnosis of hairy cell leukemia in bone marrow and spleen. Semin. Oncol 1984; 11: 334–346
   PubMed Web of Science ®Google Scholar
• Bearman R. M., Pangalis G. A., Rappaport H. Prolymphocytic leukemia. Clinical histopathological and cytochemical observations. Cancer 1978; 42: 2360–2372
   PubMed Web of Science ®Google Scholar
• Burke J. S. Surgical pathology of the spleen: An approach to the differential diagnosis of splenic lymphomas and leukemias. Am. J. Surg. 1981; 5: 551–563
   Web of Science ®Google Scholar
• Yam L. T., Janckila A. J., Li C-Y., Lam W. K. W. Cytochemistry of tartrate-resistant acid phosophatase: 15 years experience. Leukemia 1987; 1: 285–288
   PubMed Web of Science ®Google Scholar
• Anderson K. C., Boyd A. W., Fisher D. C., Leslie D., Schlossman S. K., Nadler L. M. Hairy cell leukemia: a tumor of pre-plasma cells. Blood 1985; 65: 620–629
   PubMed Web of Science ®Google Scholar
• Melo J. V., Robinson D. S. F., Gregory C., Catovsky D. Splenic B cell lymphoma with “villous” lymphocytes in the peripheral blood: A disorder distinct from a hairy cell leukemia. Leukemia 1987; 1: 294–298
   PubMed Web of Science ®Google Scholar
• Burke J. S. The value of the bone-marrow biopsy in the diagnosis of hairy cell leukemia. Am. J. Clin. Pathol. 1978; 70: 876–883
   PubMed Web of Science ®Google Scholar
• Lockney M. W., Dawson G., Golomb H. M. Effect of phorbol ester tumor promoters on hairy cell leukemic cells. Semin. Oncol 1984; 11: 433–438
   PubMed Web of Science ®Google Scholar
• Polliack A., Leizerowitz R., Gazitt Y. Phorbol esters and hairy cell leukemia: Effects on cell morphology and surface membrane features and comparison with other B cell leukemtas. Leukemia 1987; 1: 311–315
   PubMed Web of Science ®Google Scholar
• Scott C. S., Drexler H. G. Isoenzyme studies of normal and leukaemic haemopoietic cells. 'Leukaemia Cytochemistry and Diagnosis: Principles and Practice', C. S. Scott. Ellis Horwood, Chichester 1989; 295–341
   Google Scholar
• Melo J. V., San J. F. Miguel, Moss V. E., Catovsky D. The membrane phenotype of hairy cell leukemia: A study with monoclonal antibodies. Semin. Oncol. 1984; 11: 381–385
   PubMed Web of Science ®Google Scholar
• Jansen J., den Ottolander G. J., Schuit H. R. E., Waayer J. L. M., Hijmans W. Hairy cell leukemia: Its place among the chronic B cell leukemias. Semin. Oncol. 1984; 11: 386–393
   PubMed Web of Science ®Google Scholar
• Posnett D. N., Marboe C. C. Differentiation antigens associated with hairy cell leukemia. Semin. Oncol. 1984; 11: 413–415
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Nadler L. M. Cell surface markers in hematologic malignancies. Semin. Ocol. 1987; 14: 193–212
   PubMed Web of Science ®Google Scholar
• Daniel M. T., Flandrin G. Fine structure of abnormal cells in hairy cell (tricholeukocytic) leukemia with special reference to their in vitro phagocytic capacity. Lab. Invest. 1974; 30: 1–9
   PubMed Web of Science ®Google Scholar
• Nanba K., Soban E. J., Bowling M. C., Berard C. W. Splenic pseudosinuses and hepatic angiomatous lesions. Distinctive features of hairy cell leukemia. Am. J. Clin. Pathol. 1977; 67: 415–424
   PubMed Web of Science ®Google Scholar
• Jones R. A., Drexler H. G., Gignac S. M., Child J. A., Scott C. S. In-vitro beta2-microglobulin (B2m) secretion by normal and leukaemic B-cells: Effects of recombinant cytokines and evidence for a differential response to the combined stimulus of phorbol ester and calcium ionophore. Br. J. Cancer 1989, in press
   Web of Science ®Google Scholar
• Robb R. J., Greene W. C., Rusk C. M. Low and high affinity cellular receptors for interleukin-2. J. Exp. Med. 1984; 160: 1126–1146
   PubMed Web of Science ®Google Scholar
• Katayama I., Mochino T., Honma T., Fukuda M. Hairy cell leukemia: A comparative study of Japanese and non-Japanese patients. Semin. Oncol 1984; 11: 486–492
   PubMed Web of Science ®Google Scholar
• Katayama I., Hirashima K., Maruyama K., Hoshino S., Abe T., Furusawa S., Iguchi Y. Hairy cell leukemia in Japanese patients: A study with monoclonal antibodies. Leukemia 1987; 1: 301–305
   PubMed Web of Science ®Google Scholar
• Quesada J. R., Lepe-Zuniga J. L., Gutterman J. U. Mid-term observations on the efficacy of α-interferon in hairy cell leukemia and status of the interferon system of patients in remission. Leukemia 1987; 1: 317–319
   PubMed Web of Science ®Google Scholar
• Bardawil R. G., Ratain M. J., Goiomb H. M., Bitter M. A., Groves C., Vardiman J. W. Changes in peripheral blood and bone marrow specimens during and after α2b-interferon therapy for hairy cell leukemia. Leukemia 1987; 1: 340–343
   PubMed Web of Science ®Google Scholar
• Yam L. T., Klock J. C., Mielke C. H. Therapeutic leukaphoresis in hairy cell leukemia: Review of literature and personal experience. Semin. Oncol. 1984; 11: 493–501
   PubMed Web of Science ®Google Scholar
• Lehn P., Sigaux F., Grausz D., Loiseau P., Castaigne S., Degos L., Flandrin G., Dautry F. C-myc and c-fos expression during interferon-α therapy for hairy cell leukemia. Blood 1986; 68: 967–970
   PubMed Web of Science ®Google Scholar
• Creasey A. A., Bartholemew J. C., Merigan T. C. Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon. Proc. Natl. Acad. Sci. USA 1980; 77: 1471–1473
   PubMed Web of Science ®Google Scholar
• Dadmarz R., Evans T., Secher D., Marshall N., Cawley J. C. Hairy cells possess more interferon receptors than other lymphoid cell types. Leukemia 1987; 1: 357–361
   PubMed Web of Science ®Google Scholar
• Ford R. J., Kwok D., Quesada J., Sahasrabuddhe C. G. Production of B cell growth factor(s) by neoplastic B cells from hairy cell leukemia patients. Blood 1986; 67: 573–578
   PubMed Web of Science ®Google Scholar
• Paganelli K. A., Evans S. S., Han T., Ozer H. B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type I interferon in vitro. Blood 1986; 67: 937–642
   PubMed Web of Science ®Google Scholar
• Scott C. S., Ramsden W., Limbert H. J., Master P. S., Roberts B. E. Membrane transferrin receptor (TfR) and nuclear proliferation-associated Ki-67 expression in hemopoietic malignancies. Leukemia 1988; 2: 438–442
   PubMed Web of Science ®Google Scholar
• Semenzato G., Pizzola G., Agostini C., Ambrosetti A., Zambello R., Trentin L., Luca M., Masciarelli M., Chilosi M., Vinante F., Perona G., Cetto G. α-interferon activates the natural killer system in patients with hairy cell leukemia. Blood 1986; 68: 293–296
   PubMed Web of Science ®Google Scholar
• Griffiths S. D., Cawley J. C. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to the NK cell-mediated cytotoxicity. Leukemia 1987; 1: 372–376
   PubMed Web of Science ®Google Scholar